Premium
Forte Biosciences Inc (FBRX)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | Institution | 1 765 516 | 7,23% | US$ 37,13M | 2026-03-31 |
| Fred Alger Management, LLC | Institution | 1 273 965 | 5,21% | US$ 26,79M | 2026-03-31 |
| OrbiMed Advisors LLC | Institution | 1 196 955 | 4,90% | US$ 25,17M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 1 188 060 | 4,86% | US$ 24,98M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 062 182 | 4,35% | US$ 22,34M | 2026-06-04 |
| Affinity Healthcare Fund, LP | Institution | 1 011 890 | 4,14% | US$ 21,28M | 2026-03-31 |
| Affinity Asset Advisors, LLC | Institution | 1 011 890 | 4,14% | US$ 21,28M | 2026-03-31 |
| MPM BioImpact LLC | Institution | 1 000 682 | 4,10% | US$ 21,04M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 950 000 | 3,89% | US$ 19,98M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 950 000 | 3,89% | US$ 19,98M | 2026-03-31 |
| Point72 Associates, LLC | Institution | 792 976 | 3,25% | US$ 16,68M | 2026-01-16 |
| Tybourne Capital Management (HK) Ltd. | Institution | 786 647 | 3,22% | US$ 16,54M | 2025-09-30 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 690 743 | 2,83% | US$ 14,53M | 2025-04-30 |
| Vanguard Capital Management, LLC | Institution | 531 692 | 2,18% | US$ 11,18M | 2026-03-31 |
| Morgan Stanley | Institution | 500 298 | 2,05% | US$ 10,52M | 2026-03-31 |
| Ikarian Healthcare Master Fund, L.P. | Institution | 402 038 | 1,65% | US$ 8,45M | 2024-12-30 |
| Cable Car Capital LLC | Institution | 400 000 | 1,64% | US$ 8,41M | 2026-03-31 |
| FMR LLC | Institution | 340 695 | 1,39% | US$ 7,16M | 2026-03-31 |
| Woodline Partners LP | Institution | 331 987 | 1,36% | US$ 6,98M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 305 566 | 1,25% | US$ 6,43M | 2025-04-30 |
| OrbiMed Private Investments IX, LP | Institution | 300 000 | 1,23% | US$ 6,31M | 2024-12-30 |
| Biotechnology Value Fund II, L.P. | Institution | 246 319 | 1,01% | US$ 5,18M | 2025-04-30 |
| Citadel Advisors LLC | Institution | 233 369 | 0,96% | US$ 4,91M | 2026-03-31 |
| OrbiMed Genesis Master Fund, L.P. | Institution | 210 000 | 0,86% | US$ 4,42M | 2024-12-30 |
| AWM Investment Company Inc | Institution | 200 000 | 0,82% | US$ 4,21M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 184 984 | 0,76% | US$ 3,89M | 2026-03-31 |
| Marshall Wace LLP | Institution | 150 307 | 0,62% | US$ 3,16M | 2026-03-31 |
| Integral Health Asset Management, LLC | Institution | 150 000 | 0,61% | US$ 3,15M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 133 494 | 0,55% | US$ 2,81M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 125 442 | 0,51% | US$ 2,64M | 2026-03-31 |
| Ikarian Capital, LLC | Institution | 118 972 | 0,49% | US$ 2,50M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 114 635 | 0,47% | US$ 2,41M | 2026-03-31 |
| Columbia Management Investment Advisers, LLC | Institution | 111 788 | 0,46% | US$ 2,35M | 2026-03-31 |
| Perceptive Life Sciences Master Fund, Ltd. | Institution | 95 742 | 0,39% | US$ 2,01M | 2024-12-31 |
| Russell Investment Management, LLC | Institution | 91 772 | 0,38% | US$ 1,93M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 85 969 | 0,35% | US$ 1,81M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 84 803 | 0,35% | US$ 1,78M | 2026-03-31 |
| Trexquant Investment LP | Institution | 73 651 | 0,30% | US$ 1,55M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
